retatrutide side effects trial results GLP-1 Effects: Retatrutide, Tirzepatide & Semaglutide Compared Tirzepatide vs. Retatrutide: Key Differences

As of mid-2025, retatrutide remains in clinical trials and has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

While retatrutide itself is not controlled at the federal level, individual state laws can create additional requirements or restrictions

Research continues to show that protein-rich foods, fibre-rich carbohydrates, and healthy unsaturated fats can naturally increase your bodys GLP-1 release

If you're currently using the 2.4 mg semaglutide injection once a week and you're doing so privately, you don't have to start from scratch

Retatrutide helps the body reduce calorie intake by lowering appetite and cravings, but it also stimulates fat metabolism through its glucagon activity